Jonathan D. Auten

Jonathan D. Auten

Auto-generated profile, based on publicly available information

Jonathan D. Auten

Naval Medical Center San Diego, Department of Emergency Medicine, 34800 Bob Wilson Drive, San Diego, CA 92134

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
JAJonathan D. Auten
Jonathan D. Auten
NLNicole L. Lunceford
Nicole L. Lunceford
JHJaime L. Horton
Jaime L. Horton
MGMike R. Galarneau
Mike R. Galarneau
RGRoger M. Galindo
Roger M. Galindo
CDChris B. Dewing
Chris B. Dewing
In Afghanistan, care of the acutely injured trauma patient commonly occurred in facilities with limited blood banking capabilities. Apheresis platelets were often not available. Component therapy consisted of 1:1 packed red blood cells and fresh frozen plasma. Fresh, whole blood transfusion often augmented therapy in the severely injured patient. This study analyzed the safety of fresh, whole blood use in a resource-limited setting. A retrospective analysis was performed on a prospectively collected data set of US battle injuries presenting to three US Marine Corps (USMC) expeditionary surgical care facilities in Helmand Province, Afghanistan, between January 2010 and July 2012. Included in the review were patients with Injury Severity Scores (ISSs) of 15 or higher receiving blood transfusions. Univariate analyses were performed, followed by multivariable logistic regression to describe the relationship between the treatment group and posttreatment complications such as trauma-induced coagulopathy, infection, mortality, venous thromboembolism, and transfusion reaction. Propensity scores were calculated and included in multivariable models to adjust for potential bias in treatment selection. A total of 61 patients were identified; all were male marines with a mean (SD) age of 23.5 (3.6) years. The group receiving fresh, whole blood was noted to have higher ISSs and lower blood pressure, pH, and base deficits on arrival. Traumatic coagulopathy was significantly less common in the group receiving fresh, whole blood (odds ratio, 0.01; 95% confidence interval, 0.00–0.18). Multivariable models found no other significant differences between the treatment groups. The early use of fresh, whole blood in a resource-limited setting seems to confer a benefit in reducing traumatic coagulopathy. This study’s small sample size precludes further statement on the overall safety of fresh, whole blood use. Therapy study, level IV.

1 December 2013 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
LHLesley A. Hawley
Lesley A. Hawley
JAJonathan D. Auten
Jonathan D. Auten
MMMichael J. Matteucci
Michael J. Matteucci
LDLawrence Decker
Lawrence Decker
NHNicole Hurst
Nicole Hurst
RCRichard F. Clark
Richard F. Clark

1 September 2007 in Pediatric Emergency Care
Verified
Journal Article
Closed access
MMMichael J. Matteucci
Michael J. Matteucci
JAJonathan D. Do Auten
Jonathan D. Do Auten
BCBrian Crowley
Brian Crowley
DCDaniel Combs
Daniel Combs
RCRichard F. Clark
Richard F. Clark
Objectives: Methamphetamine abuse is reaching epidemic proportions. As this occurs, the likelihood of accidental poisoning in children increases. We sought to evaluate the presentation, treatment, and outcome of pediatric methamphetamine exposures reported to the California Poison Control System. Methods: This is a retrospective review of California Poison Control System records for methamphetamine exposure from 2000 through 2004. All charts of patients identified as younger than 6 years were reviewed and abstracted. Results: The charts of 47 children younger than 6 years were identified and reviewed. Three were coded as minor effects, 3 as major effects, and 16 as moderate effects. The remainder of the charts were not evaluated because of no effect (n = 6), unrelated or confirmed nonexposure (n = 3), or unable to follow (n = 16). The most common presenting symptom was agitation (82%), whereas seizures were documented in only 2 cases (9%). Tachycardia was common (mean heart rate, 171 beats/min; confidence interval [CI], 154-187), whereas blood pressure (BP) (mean systolic BP, 120 mm Hg; CI, 104-136; and mean diastolic BP, 70 mm Hg; CI, 51-88) and rectal temperature (mean, 37.4°C; CI, 36.9-37.9) were slightly elevated compared with normal values. Creatinine was documented in 6 cases and noted as normal in all (0.3IU/L; CI, 0.2-0.4), whereas creatine kinase was documented in 3 charts and elevated in all (mean 1984 IU/L; range, 212-4942 IU/L). Most cases (55%) received benzodiazepines as treatment, although only 2 received activated charcoal. Symptoms persisted for an average of 22 hours (CI, 16.3-27.2). No deaths were reported. Conclusions: In this series of children, methamphetamine exposure was strongly associated with agitation that was successfully treated with benzodiazepines. Tachycardia was common, although hypertension and hyperthermia were not. Laboratory studies were not routinely recorded. The clinical significance of elevated creatine kinase concentrations recorded in 3 children is unclear.

6 October 2018 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
JHJenny M. Held
Jenny M. Held
CMChristian S. McEvoy
Christian S. McEvoy
JAJonathan D. Auten
Jonathan D. Auten
SFStephen L. Foster
Stephen L. Foster
RRRobert L. Ricca
Robert L. Ricca

1 March 2015 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
JAJonathan D. Auten
Jonathan D. Auten
ERElliot M. Ross
Elliot M. Ross
MFMichelle A. French
Michelle A. French
ILIvy Z. Li
Ivy Z. Li
LRLovette Robinson
Lovette Robinson
DTDavid A. Tanen
David A. Tanen

1 April 2010 in Aviation, Space, and Environmental Medicine
Verified
Journal Article
Closed access
JAJonathan D. Auten
Jonathan D. Auten
MKMichael A. Kuhne
Michael A. Kuhne
HWHarlan M. Walker
Harlan M. Walker
HPHenry O. Porter
Henry O. Porter
Auten JD, Kuhne MA, Walker II HM, Porter HO. Neurologic decompression sickness following cabin pressure fluctuations at high altitude. Aviat Space Environ Med 2010; 81:427–30. Decompression sickness (DCS) occurs in diving, altitude chamber exposures, and unpressurized or depressurized high-altitude flights. Because DCS takes many forms, in-flight cases may be misinterpreted as hypoxia, hyperventilation, or viral illness, with resulting failure to respond appropriately. In this case, a 28-yr-old male pilot of a single-seat, tactical aircraft experienced 12 rapid pressure fluctuations while flying at 43,000 ft above sea level. He had no symptoms and decided to complete the flight, which required an additional 2 h in the air. Approximately 1 h later he began to experience fatigue, lightheadedness, and confusion, which he interpreted as onset of a viral illness. However, symptoms progressed to visual, cognitive, motor, and sensory degradations and it was with some difficulty that he landed safely at his destination. Neurologic DCS was suspected on initial evaluation by flight line medical personnel because of the delayed onset and symptom progression. He was transferred to a local Emergency Department and noted to have altered mental status, asymmetric motor deficits, and non-dermatomal paresthesias of the upper and lower extremities. Approximately 3.5 h after the incident and 2.5 h after the onset of symptoms he began hyperbaric oxygen therapy. He received partial relief at 30 min of the Navy Dive Table 6 and full resolution at 90 min; there were no recurrent symptoms at a 1-yr follow-up. This case highlights the importance of early recognition of in-flight DCS symptoms and landing as soon as possible rather than as soon as practical in all likely scenarios.